An Open-label Study of XEN1101 in Epilepsy
An Open-label Study of XEN1101 in Epilepsy
Enrolling by invitation · NCT05718817 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Study of XEN1101 in Epilepsy | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tonic-Clonic Seizures, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsy | Enrolling by invitation | Phase 3 | 2026-10-08 | NCT05718817 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Worldwide Clinical Trials | 13 |
| Xenon Pharmaceuticals Inc. | 9 |
152 results · Page 1 of 7
Research sites
Swipe the table sideways for more columns.